Fair Value Calculator Fair Value Calculator
EN DE

COSYN (COSYN) Fair Value & Analysis

IN · Market cap ₹149M

C COSYN COSYN · BSE
Price₹19.89
Fair Value₹2.98
Upside-85.0%
Quality45/100
Watch COSYN for free — get notified when fair value or trend changes. Watch for free
Evidence: Medium Range ₹1.90 – ₹3.73

Fair value as of: Jul 5, 2026

From 12 valuation models · updated today

Share price −3.9% over the past month.

Price vs Fair Value (12 months)

₹28.42 ₹19.21 Fair Value ₹2.98 Jul 2025 Jul 2026

12‑month range ₹19.21 – ₹28.42 · fair‑value band ₹1.90 – ₹3.73 · the ₹19.89 price screens above the ₹2.98 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

COSYN (COSYN) currently trades at ₹19.89, while our model-based Fair Value estimate is ₹2.98 — implying the stock looks roughly 85.0% overvalued today. We read business quality at 45/100 (below-average quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, COSYN generated revenue of ₹140M at a net margin of 1.1%. Revenue declined 35.5% year over year. It earns a return on equity of 0.6%. Net debt stands at ₹39.5M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹1.90 (bear case) to ₹3.73 (bull case); at ₹19.89, the current price sits above that range. The share trades about 33% below its 52-week high and 7% above its 52-week low, currently below its 200-day average.

Key figures & financial health

Revenue (TTM) ₹140M
Revenue growth (YoY) -35.5%
Net margin 1.1%
Return on equity 0.6%
Free cash flow −₹938K FY2025
P/E ratio 132.6
More key figures
Operating margin 2.5%
EPS (TTM) ₹0.1500
EPS growth (YoY) -20.0%
Net debt ₹39.5M FY2024

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

COSYN reported revenue of ₹109M in FY2025 versus ₹135M in FY2021, a compound −5.2%/yr. Reported net income was ₹1.1M in FY2025.

Revenue −5.2%/yr
FY21 ₹135M
FY22 ₹151M
FY23 ₹155M
FY24 ₹148M
FY25 ₹109M
Net income
FY21 −₹1.5M
FY22 ₹2.5M
FY23 ₹353K
FY24 ₹1.6M
FY25 ₹1.1M

Is COSYN fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "COSYN Fair Value". https://www.fairvalue-calculator.com/stock/COSYN

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is COSYN (COSYN) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹2.98 versus a price of ₹19.89 — about −85% (overvalued). Model-based estimate, not financial advice.
What is the fair value of COSYN?
Our model-based fair value for COSYN is ₹2.98 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹19.89.
What is the quality score of COSYN?
COSYN has a Quality Score of 45/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of COSYN (COSYN)?
COSYN reported trailing-twelve-month revenue of about ₹140M (latest available figure, as of Jul 5, 2026).
What is the net profit margin of COSYN?
The net profit margin of COSYN is about 1.1%, meaning it keeps roughly 1.1% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.